Hopp til innhold

Get alerts of updates about «An evidence and gap map on treatment of illnesses in women»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • An evidence and gap map on treatment of illnesses in women

Mapping review

An evidence and gap map on treatment of illnesses in women

Published

We have created an evidence and gap map of systematic reviews about treatment of illnesses that only affect women, and illnesses assumed to affect people differently depending on sex.

Forside FORSKNINGSKART KVINNESYKDOMMER.jpg

We have created an evidence and gap map of systematic reviews about treatment of illnesses that only affect women, and illnesses assumed to affect people differently depending on sex.


Downloadable as PDF. In Norwegian. Key Messages in English.

About this publication

  • Year: 2022
  • By: Norwegian Institute of Public Health
  • Authors Vist GE, Hestevik CH, Forsetlund L, Hval G, Underland V, Kucuk B, Kirkehei I.
  • ISBN (digital): 978-82-8406-295-2

Key message

We have created an evidence and gap map of systematic reviews about treatment of illnesses that only affect women, and illnesses assumed to affect people differently depending on sex.

We identified systematic reviews through systematic literature searches, assessed references against our eligibility criteria and coded included reviews according to a pre-specified coding system. We found:

  • 1739 systematic reviews pertaining to treatment of illnesses that only affect women
  • 777 systematic reviews pertaining to treatment of illnesses that may affect people differently depending on sex and that provided separate analysis on sex
  • 587 systematic reviews pertaining to treatment of breast cancer

More than half of the systematic reviews about treatment of illnesses affecting women in particular were conducted on women of fertile age.

There were few systematic reviews concerning treatment of children (0 to 12 years, 1%), adolescents (13 to 17 years, 2%), pensioners (67 to 79 years, 1%) or elderly patients (80 years +, 1%).

We did not identify any systematic reviews for two of the 26 prespecified illnesses affecting women only. We did not find any systematic reviews pertaining to 15 of the 77 prespecified illnesses that may affect people differently depending on sex.

This evidence and gap map does not assess single studies, the actual effect of the treatments nor the quality of the research.